Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
University of Washington
M.D. Anderson Cancer Center
City of Hope Medical Center
MPN Research Foundation
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
AbbVie
University Health Network, Toronto
Astex Pharmaceuticals, Inc.
Fox Chase Cancer Center
University of Nebraska
Lynk Pharmaceuticals Co., Ltd
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Mayo Clinic
University of Utah
Roswell Park Cancer Institute
University of Illinois at Chicago
Wake Forest University Health Sciences
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
OHSU Knight Cancer Institute
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Galena Biopharma, Inc.
Alliance for Clinical Trials in Oncology
Yale University